APA (7th ed.) Citation

Zhang, M., Wang, M., Jiang, Z., Fu, Z., Ma, J., & Gao, S. Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. Wiley.

Chicago Style (17th ed.) Citation

Zhang, Meng, Mei Wang, Zhiming Jiang, Ziyi Fu, Jingjing Ma, and Sheng Gao. Candidate Oligo Therapeutic Target, MiR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. Wiley.

MLA (9th ed.) Citation

Zhang, Meng, et al. Candidate Oligo Therapeutic Target, MiR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. Wiley.